Welcome To Your
Cancer Support Group !

We are always in the process of updating this site to continue bringing fellow Rotarians the latest cancer treatment information

Mission Statement

To provide up-to-date cancer treatment information for Rotarians and others along with a discussion forum to help those with cancer gain the necessary knowledge to make informed decisions about their treatment options. In furtherance of our mission we will actively promote cancer screening, participation in clinical trials, cord blood banking, improved cancer care, and cancer research throughout the world.

What’s New? Latest Break-through cancer information or article. We’ll feature 2-3 new abstracts each couple of weeks from Reuters Abstract Service, Pub MED, U of Pennsylvania abstract service, Lancet, New England Journal of Medicine, and others. (see current features on the website).

There really is a treatment for Pancreatic Cancer!

Epeius Pharmaceuticals announced that the U.S. FDA has granted Phase 3 status for the Company's lead anti-cancer agent, Rexin-G, the first, and so far only, targeted gene delivery system developed to seek out and destroy metastatic cancer. According to Dr. Maria Gordon, Chief Medical Officer of Epeius, "What this means, in terms of clinical development, is that the Rexin-G product, with its advanced GMP manufacturing, bio-processing, and final formulation, meets rigorous FDA standards for obtaining a marketing license in the future; and that Epeius Biotech can now proceed with its strategic, diversified Phase 3 drug development program for pancreatic cancer, osteosarcoma and soft tissue sarcoma."

In addition to these high-priority programs, Rexin-G has demonstrated significant anti-tumor activity in chemotherapy-resistant breast cancer, hormone-refractory prostate cancer, ovarian cancer, squamous cell carcinoma, and certain hematologic malignancies, such as large B-cell lymphoma.

Epeius Biotechnologies continues to lead the field of genetic medicine with the development of its product pipeline, which includes Reximmune-C, a tumor-targeted gene delivery system for 'personalized' cancer vaccinations, administered to stimulate a long-lasting anti-tumor immunity. CLICK HERE to watch this great video of how Rexin-G works.

Cancer Vaccines

Cancer vaccines are intended either to treat existing cancers (therapeutic vaccines) or to prevent the development of cancer (prophylactic vaccines). Both types of vaccines have the potential to reduce the burden of cancer. (more)

Prostate Cancer Update

The management of prostate cancer is enigmatic. During the past decade, the advocates of radical prostatectomy have jousted with the opponents of external beam radiotherapy, and interstitial radiation treatment. These debates have created confusion in the minds of people with prostate cancer. Obviously if there are this many solutions to the problem, the issues remain unresolved. 

The issue of prostate cancer is multifaceted, involving speculations, illusions, differing experiences, rigid dogmas, as well as new horizons. (more)

Order Your New Book

$49.95

(Free w/Lifetime enrollment of $140.00)

Proceeds are dedicated to providing

the latest cancer treatment information to patients and doctors

Colorectal Screening Kit

$14.95 or 4 for $50

Guest Article Links

·         Lung Cancer

·         Proton Beam Therapy

·         Cord Blood

·         Anti-oxidents

·         Complementary treatments

·         Breast Thermography